Patients using diabetes apps can miss critical alerts. Here’s how to make sure you’re getting them
U.S. officials are warning about a potentially life-threatening issue with smartphone apps that help manage diabetes.
The Highland County Press46m
FDA approves novel non-opioid treatment for moderate to severe acute pain
The U.S. Food and Drug Administration has approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid analgesic, to treat moderate to severe acute pain in adults. Journavx ...